Methods utilizing microRNA to treat motor neuron degeneration
Methods utilizing microRNA to treat motor neuron degeneration
Docket Number
13A-1061220
IP Status
TW I818006、US、EP、CN pending
Abstract
The invention provide a novel method of treating motor neuron degeneration in a subject. The method includes administering to a subject in need a vector to deliver a miRNA or a combo of several miRNAs for the use in the treatment, delay or melioration of motor neuron degeneration in MN diseases, including ALS and SMA.
Technological Advantages
- Several studies revealed that delivery of miRNA targeting to SOD1 can reduce mutant SOD1 toxicity in spinal MNs and prolong lifespans of SOD1G93A ALS mice by 9 to 20 days. However, this strategy is only applicable to a minor fALS population.
- Our current invention can prolong the lifespan of ALS mice for about 20 days, which is comparable, even superior to the above therapy. Of noted, miRNAs used in this invention enhances the common protective pathway in motor neurons, meaning that this invention has the clinical potential to apply to all ALS types and even other MN degenerative diseases.
Applications of Technology
The invention can be applied to delay or melioration of motor neuron degeneration in MN diseases, including ALS and SMA.
Inventor
Jun-An Chen
Contact person
If you are interested in this technology, please fill in the information on the webpage under the manufacturer option (Request for Technology Licensing, Material Transfer, or Sponsored Research) on the website of this office

Methods utilizing microRNA to treat motor neuron degeneration